Swedbank AB Has $79.81 Million Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Swedbank AB decreased its position in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 7.1% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 265,898 shares of the company's stock after selling 20,321 shares during the period. Swedbank AB owned about 0.10% of HCA Healthcare worth $79,809,000 at the end of the most recent reporting period.

Other hedge funds also recently modified their holdings of the company. Legacy Investment Solutions LLC purchased a new stake in shares of HCA Healthcare in the third quarter worth approximately $39,000. Capital Performance Advisors LLP purchased a new position in shares of HCA Healthcare during the 3rd quarter valued at $41,000. Canoe Financial LP acquired a new stake in HCA Healthcare during the third quarter valued at $41,000. Northwest Investment Counselors LLC acquired a new position in HCA Healthcare in the 3rd quarter worth about $44,000. Finally, Friedenthal Financial acquired a new stake in shares of HCA Healthcare during the 3rd quarter valued at about $50,000. Hedge funds and other institutional investors own 62.73% of the company's stock.

Wall Street Analyst Weigh In

HCA has been the subject of a number of analyst reports. Cantor Fitzgerald reiterated an "overweight" rating and issued a $405.00 target price on shares of HCA Healthcare in a research note on Monday. Barclays reduced their price target on HCA Healthcare from $392.00 to $366.00 and set an "overweight" rating for the company in a research report on Monday. Wells Fargo & Company downgraded HCA Healthcare from an "equal weight" rating to an "underweight" rating and cut their price objective for the company from $400.00 to $320.00 in a research note on Monday, November 25th. KeyCorp cut their target price on shares of HCA Healthcare from $420.00 to $370.00 and set an "overweight" rating for the company in a research report on Tuesday, January 7th. Finally, TD Cowen lowered their target price on HCA Healthcare from $450.00 to $440.00 and set a "buy" rating on the stock in a report on Monday, October 28th. One analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have given a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average target price of $382.19.

Insider Activity at HCA Healthcare

In related news, insider Erol R. Akdamar sold 2,900 shares of the stock in a transaction that occurred on Thursday, November 14th. The stock was sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the completion of the sale, the insider now directly owns 6,843 shares of the company's stock, valued at approximately $2,415,579. This represents a 29.76 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, SVP Phillip G. Billington sold 3,897 shares of the company's stock in a transaction that occurred on Thursday, November 14th. The shares were sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the completion of the transaction, the senior vice president now owns 52,702 shares of the company's stock, valued at $18,445,700. This trade represents a 6.89 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 1.60% of the company's stock.

HCA Healthcare Price Performance

NYSE:HCA traded up $9.11 during mid-day trading on Thursday, reaching $336.73. 411,011 shares of the company were exchanged, compared to its average volume of 1,709,281. The company has a quick ratio of 1.00, a current ratio of 1.12 and a debt-to-equity ratio of 48.71. The stock has a market cap of $85.29 billion, a PE ratio of 15.11, a PEG ratio of 1.09 and a beta of 1.64. The company has a fifty day moving average of $313.18 and a 200 day moving average of $353.09. HCA Healthcare, Inc. has a 12 month low of $289.98 and a 12 month high of $417.14.

HCA Healthcare (NYSE:HCA - Get Free Report) last released its earnings results on Friday, January 24th. The company reported $6.22 earnings per share for the quarter, topping analysts' consensus estimates of $6.03 by $0.19. HCA Healthcare had a return on equity of 520.98% and a net margin of 8.52%. During the same quarter in the prior year, the company earned $5.90 earnings per share. On average, research analysts anticipate that HCA Healthcare, Inc. will post 21.75 EPS for the current fiscal year.

HCA Healthcare Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, March 31st. Stockholders of record on Monday, March 17th will be paid a $0.72 dividend. The ex-dividend date is Monday, March 17th. This is a boost from HCA Healthcare's previous quarterly dividend of $0.66. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.86%. HCA Healthcare's dividend payout ratio is 11.85%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.